Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a stethoscope and heart symbolizing healthcare technology.

Oct 21, 2026

Rural hospital independence depends on making technology count

Rural hospitals face mounting challenges in maintaining independence amid financial pressures and competition, but strategic technology investments can offer a path to sustainability.Independence for rural hospitals is increasingly precarious due to tight financial margins, workforce shortages, and the encroachment of larger health systems. Susi VonBergen, a healthcare leader at Nemaha County Hospital in Nebraska, emphasizes that these institutions must deliver safe, cost-effective patient care
Press release cover image

Oct 21, 2026

Press release

Therna Biosciences Showcases RNA-Logix™, Its AI RNA Biologist Platform for Biological Discovery and Genomic Medicine Design

RNA-Logix connects biological questions, experimental evidence, and RNA medicine design in a single investigative workflowThe platform integrates NVIDIA accelerated computing and BioReason-RNA, a model developed in collaboration with NVIDIA that predicts RNA function and proposes the mechanisms behind itSAN FRANCISCO--(BUSINESS WIRE)--Therna Biosciences, a biotechnology company translating RNA language into genomic medicines, today showcased RNA-Logix™, its Recursive AI RNA Biologist platform. R
Press release cover image

Oct 21, 2026

Press release

egnite 2026 Benchmark Report: Four-Class GDMT Prescribing in Systolic Heart Failure More Than Doubles, Yet Four in Five Patients Are Not Prescribed Full Guideline Therapy

Real-world data from 47 U.S. health systems shows three-year survival of 76% among systolic heart failure patients prescribed four GDMT classes, versus 52% among those prescribed noneALISO VIEJO, Calif., Oct. 21, 2026 /PRNewswire/ -- egnite, Inc., a technology company advancing guideline-directed cardiovascular care and real-world evidence, today released its 2026 Benchmark Report on Heart Failure and Structural Heart, which examines how cardiovascular care is delivered across 47 U.S. health sys
Press release cover image

Oct 21, 2026

Press release

iReprogram Partners with University of Michigan on Multimillion-Dollar Initiative to Reprogram Cells for Diabetes

Backed by the Look to Michigan Strategic Initiative Fund, the collaboration aims to accelerate patient-derived cell therapies to pioneer comprehensive diabetes treatments.ANN ARBOR, Mich., Oct. 21, 2026 /PRNewswire/ --  iReprogram, spun out of the University of Michigan (U-M), was named lead industry partner in the newly launched Michigan Initiative to Reprogram Cells for Diabetes (MIRC-D). Supported by the U-M Strategic Initiative Fund, the multimillion-dollar effort unites experts across seven
A minimalist representation of a lipid nanoparticle and drug molecule.

Oct 21, 2026

AI meets big pharma: METiS partners with Lilly to reinvent drug delivery

METiS TechBio has entered a significant partnership with Eli Lilly, valued at $1.1 billion, to innovate drug delivery through AI-enhanced lipid design.This collaboration focuses on developing advanced lipid nanoparticle (LNP)-based delivery systems, aiming for more accurate and tissue-specific therapeutic delivery. METiS will receive an initial payment in the low double-digit millions, alongside potential milestone payments and royalties based on the sales of resultant products. Central to this
Press release cover image

Oct 21, 2026

Press release

Reproductive Solutions Introduces First-of-Its-Kind Sperm Preparation Workflow Calculator for Fertility Laboratories

New online tool enables fertility professionals to compare sperm preparation methods and evaluate differences in processing time, labor, consumables, and operational costs.FRISCO, Texas, Oct. 21, 2026 /PRNewswire/ -- Reproductive Solutions (RSI Technology Group), an innovator in reproductive laboratory technologies, today announced the launch of its Sperm Preparation Workflow Calculator, a new online resource designed to help fertility laboratories quantify and compare the operational demands of
Press release cover image

Oct 21, 2026

Press release

RVO Health Receives Third U.S. Patent for Script Portability, Technology That Lets Consumers Choose Where to Fill Their Prescriptions

Script Portability shows consumers their pharmacy options before a prescription is sent, so they can choose based on price and convenienceNEW YORK, Oct. 21, 2026 /PRNewswire/ -- RVO Health today announced that the U.S. Patent and Trademark Office (USPTO) has granted the company its third U.S. patent in the Siegel family, strengthening its intellectual property portfolio and reinforcing its position as an innovative leader in the Consumer HealthTech space.U.S. Patent No. 12,580,060 B2, along with
Press release cover image

Oct 21, 2026

Press release

Surgical Science and CHEST Mark 10 Years: Transforming Chest Medicine Competency through Simulation Training for Thousands of Clinicians

GOTHENBURG, Sweden, Oct. 21, 2026 /PRNewswire/ -- Surgical Science, the global leader in simulation products for healthcare training, is marking its 10-year anniversary of the company's partnership with the American College of Chest Physicians® (CHEST). The teams are celebrating their decade-long partnership, the launch of a new simulated curriculum, and the importance of combining education with simulation technology at the CHEST 2026 Annual Meeting in Phoenix and throughout the year at the CHE
Press release cover image

Oct 21, 2026

Press release

Right2Hope Launches Free Cancer Treatment Search Platform to Help Patients Explore Investigational Therapies

Nonprofit resource helps advanced cancer patients and oncologists find experimental treatments to explore via expanded access and Right to TryDALLAS, Oct. 21, 2026 /PRNewswire/ -- For patients with advanced cancer who have exhausted standard treatment options, the hardest question is often: What else is out there?Today, nonprofit Right2Hope launched www.right2hope.org, a free online platform that helps patients, families, and oncologists identify investigational cancer therapies worth exploring
A minimalist illustration of a syringe symbolizing clinical trials.

Oct 21, 2026

Oracle and AstraZeneca to collaborate on 'smarter' clinical trials

AstraZeneca and Oracle Health have announced a partnership aimed at enhancing clinical trial processes through artificial intelligence (AI), addressing significant challenges in patient safety and recruitment.The collaboration seeks to develop a continuous learning model that leverages insights from both clinical research and routine healthcare. By utilizing real-world data, the initiative aims to identify eligible patients for clinical trials more effectively, thus streamlining the research pro
A laboratory flask with a biological sample on a lab bench

Oct 21, 2026

OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools

OpenAI has acquired Orchestra Bio, a biotechnology startup, to enhance its life sciences AI capabilities through integration into its existing Rosalind platform.This acquisition involves the incorporation of Orchestra's technology and team into Rosalind, OpenAI's suite of AI models designed for life sciences research. Although the financial details of the deal remain undisclosed, the merger is expected to bolster OpenAI's efforts in streamlining the research process. Orchestra's platform allows
Press release cover image

Oct 21, 2026

Press release

Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery

DRAGEN Ultra, BioInsight Platform Workflow Orchestrator, and BioInsight Platform Learning Cohorts are now available in early access, incorporating new AI-driven approaches to analysis, automation, and discoveryThe tools automate end-to-end informatics processes at scale and help customers build private data lakes to drive scientific and clinical research insightsSAN DIEGO, Oct. 21, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today introduced three early-access capabilities on its BioInsig